Literature DB >> 10534017

Hypericin-induced phototoxicity of human leukemic cell line HL-60 is potentiated by omeprazole, an inhibitor of H+K+-ATPase and 5'-(N,N-dimethyl)-amiloride, an inhibitor of Na+/H+ exchanger.

L Mirossay1, A Mirossay, E Kocisová, I Radváková, P Miskovský, J Mojzis.   

Abstract

Hypericin, an antiretroviral and antineoplastic agent, seems to have multiple modes of light-induced biological activity connected with the production of single oxygen and/or excited-state proton transfer and a consequent pH drop of pH formation in the hypericin environment. In the present study omeprazole, an inhibitor of H+K+-ATPase, and amiloride, an inhibitor of the Na+/H+ exchanger, have been used for testing the hypothetical pH decreasing effect of hypericin in its antineoplastic action. The results of our experiments have shown that in the HL-60 cell line the effect of hypericin (10(-6) mol.l(-1)) was significantly potentiated by omeprazole and 5'-(N,N-dimethyl)-amiloride. The effect of omeprazole seemed to be less specific than that of 5'-(N,N-dimethyl)-amiloride. Our results support the hypothesis that the excited-state proton transfer and the consequent acidification of the hypericin environment could play a role in the biological activity of hypericin. Moreover, both omeprazole and 5'-(N,N-dimethyl)-amiloride are effective potentiating agents of hypericin cytotoxic effect in the HL60 cell line.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534017

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  6 in total

1.  Role of PEPT2 in the choroid plexus uptake of glycylsarcosine and 5-aminolevulinic acid: studies in wild-type and null mice.

Authors:  Scott M Ocheltree; Hong Shen; Yongjun Hu; Jianming Xiang; Richard F Keep; David E Smith
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

2.  Significance and regional dependency of peptide transporter (PEPT) 1 in the intestinal permeability of glycylsarcosine: in situ single-pass perfusion studies in wild-type and Pept1 knockout mice.

Authors:  Dilara Jappar; Shu-Pei Wu; Yongjun Hu; David E Smith
Journal:  Drug Metab Dispos       Date:  2010-07-21       Impact factor: 3.922

3.  Drug Repurposing of Pantoprazole and Vitamin C Targeting Tumor Microenvironment Conditions Improves Anticancer Effect in Metastatic Castration-Resistant Prostate Cancer.

Authors:  Zhoulei Li; Peng He; Yali Long; Gang Yuan; Wanqing Shen; Zhifeng Chen; Bing Zhang; Yue Wang; Dianchao Yue; Christof Seidl; Xiangsong Zhang
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

4.  Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells.

Authors:  Andrej Udelnow; Andreas Kreyes; Stefan Ellinger; Katharina Landfester; Paul Walther; Thomas Klapperstueck; Johannes Wohlrab; Doris Henne-Bruns; Uwe Knippschild; Peter Würl
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

5.  Stable DNA Nanomachine Based on Duplex-Triplex Transition for Ratiometric Imaging Instantaneous pH Changes in Living Cells.

Authors:  Mengqi Yang; Xiaoling Zhang; Haipeng Liu; Huaizhi Kang; Zhi Zhu; Wen Yang; Weihong Tan
Journal:  Anal Chem       Date:  2015-06-02       Impact factor: 6.986

6.  Esomeprazole enhances the effect of ionizing radiation to improve tumor control.

Authors:  Kassidy A Hebert; Sergio Jaramillo; Wangjie Yu; Min Wang; Ratna Veeramachaneni; Vlad C Sandulache; Andrew G Sikora; Mark D Bonnen; Ananth V Annapragada; David Corry; Farrah Kheradmand; Raj K Pandita; Michelle S Ludwig; Tej K Pandita; Shixia Huang; Cristian Coarfa; Sandra L Grimm; Dimuthu Perera; George Miles; Yohannes T Ghebre
Journal:  Oncotarget       Date:  2021-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.